Deutsche Bank AG Purchases 5,073 Shares of Red Violet, Inc. (NASDAQ:RDVT)

Deutsche Bank AG increased its holdings in Red Violet, Inc. (NASDAQ:RDVT - Free Report) by 80.7% in the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 11,361 shares of the company's stock after buying an additional 5,073 shares during the quarter. Deutsche Bank AG owned about 0.08% of Red Violet worth $411,000 at the end of the most recent reporting period.

A number of other hedge funds have also bought and sold shares of the business. SG Americas Securities LLC boosted its stake in shares of Red Violet by 14.3% in the 4th quarter. SG Americas Securities LLC now owns 7,990 shares of the company's stock worth $289,000 after buying an additional 998 shares during the last quarter. Bank of New York Mellon Corp lifted its holdings in Red Violet by 3.2% in the fourth quarter. Bank of New York Mellon Corp now owns 34,105 shares of the company's stock valued at $1,235,000 after acquiring an additional 1,068 shares during the period. Charles Schwab Investment Management Inc. boosted its position in Red Violet by 3.8% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 32,083 shares of the company's stock worth $1,161,000 after purchasing an additional 1,181 shares during the last quarter. Barclays PLC boosted its position in Red Violet by 10.6% in the fourth quarter. Barclays PLC now owns 20,463 shares of the company's stock worth $740,000 after purchasing an additional 1,961 shares during the last quarter. Finally, Wells Fargo & Company MN grew its stake in shares of Red Violet by 58.0% during the 4th quarter. Wells Fargo & Company MN now owns 5,688 shares of the company's stock valued at $206,000 after purchasing an additional 2,089 shares during the period. Hedge funds and other institutional investors own 63.56% of the company's stock.

Red Violet Price Performance

Shares of NASDAQ:RDVT traded down $1.93 during trading on Wednesday, hitting $46.03. The company's stock had a trading volume of 86,831 shares, compared to its average volume of 76,445. The firm has a market cap of $642.39 million, a price-to-earnings ratio of 127.86 and a beta of 1.69. The company has a 50-day moving average of $41.91 and a 200-day moving average of $39.04. Red Violet, Inc. has a 12 month low of $20.61 and a 12 month high of $51.10.

Insider Activity at Red Violet

In related news, insider Jeffrey Alan Dell sold 5,000 shares of Red Violet stock in a transaction on Friday, May 9th. The stock was sold at an average price of $46.20, for a total transaction of $231,000.00. Following the transaction, the insider now directly owns 172,968 shares in the company, valued at approximately $7,991,121.60. The trade was a 2.81% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Steven D. Rubin sold 10,000 shares of the business's stock in a transaction dated Wednesday, March 19th. The shares were sold at an average price of $38.93, for a total value of $389,300.00. Following the sale, the director now directly owns 141,138 shares of the company's stock, valued at $5,494,502.34. This represents a 6.62% decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 25,000 shares of company stock worth $1,082,400. 9.50% of the stock is owned by company insiders.

Red Violet Company Profile

Red Violet, Inc, a software and services company, specializes in proprietary technologies and applying analytical capabilities to deliver identity intelligence in the United States. It offers idiCORE, an investigative solution used to address various organizational challenges, which include due diligence, risk mitigation, identity authentication, fraud detection and prevention, customer acquisition, and regulatory compliance; and FOREWARN, an app-based solution that provides instant knowledge before face-to-face engagement with a consumer, as well as helps professionals to identify and mitigate risk.